These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30070899)

  • 1. High-Content Assay Multiplexing for Muscle Toxicity Screening in Human-Induced Pluripotent Stem Cell-Derived Skeletal Myoblasts.
    Klaren WD; Rusyn I
    Assay Drug Dev Technol; 2018; 16(6):333-342. PubMed ID: 30070899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Content Assay Multiplexing for Vascular Toxicity Screening in Induced Pluripotent Stem Cell-Derived Endothelial Cells and Human Umbilical Vein Endothelial Cells.
    Iwata Y; Klaren WD; Lebakken CS; Grimm FA; Rusyn I
    Assay Drug Dev Technol; 2017; 15(6):267-279. PubMed ID: 28771372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes.
    Grimm FA; Iwata Y; Sirenko O; Bittner M; Rusyn I
    Assay Drug Dev Technol; 2015 Nov; 13(9):529-46. PubMed ID: 26539751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-content high-throughput assays for characterizing the viability and morphology of human iPSC-derived neuronal cultures.
    Sirenko O; Hesley J; Rusyn I; Cromwell EF
    Assay Drug Dev Technol; 2014; 12(9-10):536-47. PubMed ID: 25506803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and Mechanistic Neurotoxicity Profiling Using Human iPSC-Derived Neural 3D Cultures.
    Sirenko O; Parham F; Dea S; Sodhi N; Biesmans S; Mora-Castilla S; Ryan K; Behl M; Chandy G; Crittenden C; Vargas-Hurlston S; Guicherit O; Gordon R; Zanella F; Carromeu C
    Toxicol Sci; 2019 Jan; 167(1):58-76. PubMed ID: 30169818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of neuroprogenitor cells to chemical-induced apoptosis using a multiplexed assay suitable for high-throughput screening.
    Druwe I; Freudenrich TM; Wallace K; Shafer TJ; Mundy WR
    Toxicology; 2015 Jul; 333():14-24. PubMed ID: 25841707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurite outgrowth in human induced pluripotent stem cell-derived neurons as a high-throughput screen for developmental neurotoxicity or neurotoxicity.
    Ryan KR; Sirenko O; Parham F; Hsieh JH; Cromwell EF; Tice RR; Behl M
    Neurotoxicology; 2016 Mar; 53():271-281. PubMed ID: 26854185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiotoxicity Hazard and Risk Characterization of ToxCast Chemicals Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes from Multiple Donors.
    Burnett SD; Blanchette AD; Chiu WA; Rusyn I
    Chem Res Toxicol; 2021 Sep; 34(9):2110-2124. PubMed ID: 34448577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilities.
    Koci B; Luerman G; Duenbostell A; Kettenhofen R; Bohlen H; Coyle L; Knight B; Ku W; Volberg W; Woska JR; Brown MP
    Toxicol Appl Pharmacol; 2017 Aug; 329():121-127. PubMed ID: 28546047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule inhibitors promote efficient generation of induced pluripotent stem cells from human skeletal myoblasts.
    Trokovic R; Weltner J; Manninen T; Mikkola M; Lundin K; Hämäläinen R; Suomalainen A; Otonkoski T
    Stem Cells Dev; 2013 Jan; 22(1):114-23. PubMed ID: 22671711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro cardiotoxicity assessment of environmental chemicals using an organotypic human induced pluripotent stem cell-derived model.
    Sirenko O; Grimm FA; Ryan KR; Iwata Y; Chiu WA; Parham F; Wignall JA; Anson B; Cromwell EF; Behl M; Rusyn I; Tice RR
    Toxicol Appl Pharmacol; 2017 May; 322():60-74. PubMed ID: 28259702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 3D microfluidic liver model for high throughput compound toxicity screening in the OrganoPlate®.
    Bircsak KM; DeBiasio R; Miedel M; Alsebahi A; Reddinger R; Saleh A; Shun T; Vernetti LA; Gough A
    Toxicology; 2021 Feb; 450():152667. PubMed ID: 33359578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multiplexed in vitro assay system for evaluating human skeletal muscle functionality in response to drug treatment.
    Najjar SA; Smith AST; Long CJ; McAleer CW; Cai Y; Srinivasan B; Martin C; Vandenburgh HH; Hickman JJ
    Biotechnol Bioeng; 2020 Mar; 117(3):736-747. PubMed ID: 31758543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Throughput Screening Using iPSC-Derived Neuronal Progenitors to Identify Compounds Counteracting Epigenetic Gene Silencing in Fragile X Syndrome.
    Kaufmann M; Schuffenhauer A; Fruh I; Klein J; Thiemeyer A; Rigo P; Gomez-Mancilla B; Heidinger-Millot V; Bouwmeester T; Schopfer U; Mueller M; Fodor BD; Cobos-Correa A
    J Biomol Screen; 2015 Oct; 20(9):1101-11. PubMed ID: 26024946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes.
    Ware BR; Berger DR; Khetani SR
    Toxicol Sci; 2015 Jun; 145(2):252-62. PubMed ID: 25716675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional screening in human induced-pluripotent stem cell-derived cardiomyocytes accurately identifies cardiotoxicity of multiple drug types.
    Doherty KR; Talbert DR; Trusk PB; Moran DM; Shell SA; Bacus S
    Toxicol Appl Pharmacol; 2015 May; 285(1):51-60. PubMed ID: 25841593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manipulation-free cultures of human iPSC-derived cardiomyocytes offer a novel screening method for cardiotoxicity.
    Rajasingh S; Isai DG; Samanta S; Zhou ZG; Dawn B; Kinsey WH; Czirok A; Rajasingh J
    Acta Pharmacol Sin; 2018 Oct; 39(10):1590-1603. PubMed ID: 29620051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced functional cardiotoxicity screening in stem cell-derived human and mouse cardiomyocytes: effects of reference compounds.
    Himmel HM
    J Pharmacol Toxicol Methods; 2013; 68(1):97-111. PubMed ID: 23702537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic Assays for Characterizing Compound Effects on Induced Pluripotent Stem Cell-Derived Cardiac Spheroids.
    Sirenko O; Hancock MK; Crittenden C; Hammer M; Keating S; Carlson CB; Chandy G
    Assay Drug Dev Technol; 2017; 15(6):280-296. PubMed ID: 28837356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of Hepatotoxicity in iPSC-Derived Hepatocytes by Multiplexed High Content Assays.
    Sirenko O; Cromwell EF
    Methods Mol Biol; 2018; 1683():339-354. PubMed ID: 29082501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.